Abstract

Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration

Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A

Issue: May/Jun 2008 - Pain Management

Page(s): 276-278

Download in electronic PDF format for $75
  • Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Page 1
  • Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Page 2
  • Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Page 3

Abstract

The physical compatibility of caspofungin acetate injection with selected other drugs during simulated Y-site coadministration was evaluated by visual observation and turbidity measurement. Five-milliliter samples of caspofungin acetate 0.7 mg/mL in 0.9% sodium chloride injection were combined with 5 mL of 67 other drugs including antineoplastics, analgesics, anti-infectives, and supportive care drugs, undiluted or diluted in 0.9% sodium chloride injection or 5% dextrose injection, and with a parenteral nutrition admixture. Visual examinations were performed with the unaided eye in normal laboratory fluorescent light and with a Tyndall beam (high-intensity monodirectional light beam) to enhance visualization of small particles and low-level turbidity. The turbidity of each sample was measured as well. The sample mixtures were evaluated immediately and at 1 and 4 hours after preparation. Nineteen of the drugs tested and the parenteral nutrition admixture were incompatible with caspofungin acetate 0.7 mg/mL dur

Related Keywords

  • Pak Chan
  • caspofungin acetate
  • drug admixtures
  • infusion
  • Y-site administration
  • parenteral administration
  • compatibility
  • stability
  • total parenteral nutrition

Related Categories

  • PARENTERALS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2008
Pg. 276-278
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2002
Pg. 311-315
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Author(s): Trissel Lawrence A, Saenz Christopher
Jan/Feb 2001
Pg. 69-73
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Author(s): Trissel Lawrence A, Williams Kimberly Y, Baker Ma
Mar/Apr 2008
Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Jan/Feb 2021
Pg. 52-61
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2009
Pg. 78-80
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
Nov/Dec 2007
Pg. 520-524
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 230-233
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Author(s): Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2001
Pg. 314-319
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
May/Jun 1999
Pg. 241-244
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
May/Jun 2002
Pg. 230-233
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs
Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P
Mar/Apr 2025
Pg. 121
Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s):
Jul/Aug 2008
Pg. 368-371
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2013
Pg. 436-438
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration
Author(s): Ramaley Corrine C, Li Feng, Du Chengan
May/Jun 2016
Pg. 236-238
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Author(s): Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
Jul/Aug 1998
Pg. 318-321
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration
Author(s): Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Jan/Feb 2012
Pg. 82-85
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Author(s): Zhang Yang, Scarlett Cameron, Hutson Paul
Jul/Aug 1999
Pg. 303
Parenteral Admixture with Y-Site Administration
Author(s): Allen Loyd V Jr